Designing a Pediatric Study for an Antimalarial Drug by Using Information from Adults

Area of Science:

• Pharmacokinetics
• Pediatric Drug Development
• Mathematical Modeling

Background:

• Designing pediatric pharmacokinetic (PK) studies presents challenges due to limited data.
• Extrapolating adult PK data to pediatric populations requires careful consideration of physiological differences.

Purpose of the Study:

• To design a robust pharmacokinetic study for pediatric mefloquine dosing using adult data.
• To evaluate the reliability of a novel pediatric PK study design through a case study.

Main Methods:

• Developed an adult PK model and estimated parameters using the stochastic approximation expectation-maximization algorithm.
• Incorporated allometry and maturation to extrapolate adult PK parameters to pediatric populations.
• Optimized a D-optimal design for pediatric studies using the PFIM software and an extrapolated model.

Main Results:

• A pediatric PK study design with five sampling times was developed, yielding well-estimated PK parameters with low relative standard errors (RSE).
• The extrapolated model, despite not perfectly predicting observed concentrations, enabled precise and unbiased parameter estimates.
• The proposed design demonstrated robustness across various model assumptions, outperforming the empirical design.

Conclusions:

• Combining adult PK data with allometry and maturation provides a robust framework for pediatric study design.
• This approach facilitates the development of optimized and reliable dosing strategies for pediatric populations.
• The study highlights the value of model-based extrapolation in pediatric drug development.